Our immune systems are continually working to keep our bodies safe from infectious invaders. Furthermore, immune system components monitor changes in our bodies' own cells, for example, by preventing or limiting the spread of certain malignancies. Antibody-producing cells, as well as cells that attack, poison, and scavenge invading pathogens or our own injured cells, are all part of the immune system. Alzheimer's disease is predicted to be slowed or stopped by active or passive immunotherapy (AD). Immunotherapy for Alzheimer's disease has shown that vaccines or antibodies targeting beta-amyloid (A) or tau protein can lessen AD pathology. In the fight against Alzheimer's disease, immunotherapy, or the use of immune-enhancing techniques as a medical treatment, has taken two fundamental forms active and passive.
- Developing Immunotherapy
- Passive Immunization
- Active Immunotherapy
Yong Xiao Wang
Albany Medical College, United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Bin Hu
University of Calgary, Canada
Akankunda Veronicah
Executive Director, Uganda
Zhenhuan Liu
Guangzhou University of Chinese Medicine, China
Alford Madeline
CESPU University, Portugal
Charikleia Karastamati
University of Pavia, ItalySubmit your abstract Today
Important Alert:
X
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Executive Director, Uganda
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany